RepRegen™ Ltd. (Formerly Known as BioCeramic Therapeutics) Seeks US FDA 510(k) Clearance for StronBone(TM)

LONDON--(BUSINESS WIRE)--RepRegen, the ‘smart biomaterials’ company, announced today that RepRegen Inc. in the US has submitted StronBone to the U.S. FDA for 510(k) clearance.